United Therapeutics acquiring SteadyMed in deal worth $216M

United Therapeutics Corp. (NASDAQ:UTHR) is acquiring is acquiring California-based SteadyMed in a transaction valued at $216 million. SteadyMed, (NASDAQ:STDY) stock shot up 80 percent in premarket trading to $2.65 a share on the news Monday.

Read More